$885.88
+13.56(1.55%)
Mkt Cap $109.3B
$652.83
$995.69
52-Week Range
At a Glance
AI-generatedRevenue breakdown: US Pharmaceutical Segment (89.6%), International Segment (5.2%), Medical Surgical Solutions Segment (3.6%).
8-K
McKesson Corporation announced its fourth quarter fiscal 2026 financial results release date as after market close on May 7, 2026, with a conference call at 4:30 PM Eastern Time hosted by CEO Brian Tyler and CFO Britt Vitalone. The company reaffirmed its fiscal 2026 full year outlook previously issued on February 4, 2026, and disclosed CFO participation in upcoming healthcare conferences.$109.3B
Market Cap
$398.7B
Revenue
$4.3B
Net Income
Employees44,000
Fundamentals
How The Business Makes Money
Revenue by Segment
US Pharmaceutical Segment89.6%($847.1B)
International Segment5.2%($49.4B)
Medical Surgical Solutions Segment3.6%($33.8B)
Prescription Technology Solutions Segment1.5%($14.4B)
U.S.Pharmaceuticaland Specialty Solutions0.1%($1.1B)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0000927653
ISINUS58155Q1031
CUSIP58155Q103
Phone972 446 4800
Address6555 State Highway 161, Irving, TX, 75039, US
SEC EDGAR